Advanced protocols for stage 4 renal cell carcinoma with metastatic disease management.
This comprehensive protocol addresses advanced stage 4 renal cell carcinoma with specific focus on pancreatic and bone metastases. Our approach utilizes advanced nuclear medicine imaging to assess disease burden, monitor targeted therapy and immunotherapy effectiveness, and guide treatment decisions in metastatic disease. The protocol provides detailed characterization of metastatic sites, treatment response assessment, and ongoing surveillance to optimize outcomes in advanced RCC.
Patients with stage 4 RCC, pancreatic or bone metastases, or those on targeted therapy/immunotherapy requiring treatment monitoring.
Complete the form below to begin your treatment journey with our comprehensive cancer care protocol